High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00126854

Enrollment

Registered

2005-08-05

Start date

2005-10-31

Completion date

2011-04-30

Last updated

2016-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Neoplasm

Keywords

brachytherapy, magnetic resonance spectroscopy

Brief summary

The purpose of this study is to establish the correct scanning parameters for obtaining good quality 3 Tesla (3T) magnetic resonance spectroscopy images (MRSI) of the prostate gland before and after brachytherapy implantation for prostate cancer. Three Tesla MRSI may be a valuable additional diagnostic and follow-up investigation for prostate cancer patients.

Interventions

PROCEDUREMagnetic Resonance Spectroscopy Imaging

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Suitable candidate for prostate brachytherapy to treat prostate cancer * Patient signs a study consent form

Exclusion criteria

* Have received other radiotherapy for prostate cancer or hormone treatments * Has contraindication to MRSI scanning * Does not sign study consent form

Design outcomes

Primary

Measure	Time frame
pilot study meant to establish scanning parameters on 3T MRSI	—

Secondary

Measure	Time frame
safety/toxicity	—

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026